NICE (National Institute for Health and Clinical Excellence) economic model data push back DES consultation
This article was originally published in Clinica
The UK's National Institute for Health and Clinical Excellence (NICE) has extended its consultation on the use in the NHS of drug-eluting stents (DESs) to treat coronary artery disease, after the late publication of supporting documentation, Clinica has learnt.
You may also be interested in...
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.